Harte-Hanks (HHS) Misses Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q4 EPS of $0.30, $0.22 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $39.86 million versus the consensus estimate of $55.6 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Lilly breaks ground on $6.5B Houston drug manufacturing site
- Vicor raises Q3 2026 revenue guidance on new licensing deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
